Breaking Down the 2026 ADA CGM Guidelines

In 'Breaking Down the 2026 ADA CGM Guidelines,' our panel of experts delve into the following critical question:

1. What are the latest American Diabetes Association (ADA) recommendations regarding CGM devices?

Led by the moderator, Estay Greene and Victoria Bouhairie discussed the significant expansion of ADA CGM recommendations in 2026, which now extend CGM use to patients at diabetes onset or any time after, including children, adolescents, adults on insulin and non-insulin therapies that carry hypoglycemia risk, pregnant individuals, older adults, and those in the pre-symptomatic stage of type 1 diabetes. The discussion also addressed the ADA's emphasis on ensuring continued third-party payer access to CGM devices regardless of patient age or A1C levels, reinforcing that reaching glycemic goals should not result in losing access to the tools that helped achieve them.
Throughout the conversation, the experts provide a comprehensive reflection on the field and the factors that may shape how clinicians ap